All ears to the exclusive podcast with Abhishek Shah, Co-Founder, and CEO at Wellthy Therapeutics. 
 “The overwhelming data concerning digital therapeutics available across the globe have showcased that science works. And executing on that science with a personalized approach for a specific user/patient drives the success rates at scale.”-Abhishek Shah, Co-founder, and CEO at Wellthy Therapeutics. 
Abhishek Shah, Co-founder and CEO at Wellthy Therapeutics.  

About Wellthy Therapeutics

Wellthy Therapeutics, a pioneer in digital therapeutics, aims to solve the issue of chronic diseases with the disease management platform. The Wellthy Therapeutics steers forward with the mission to inspire and enable 10 million patients to reverse, prevent, or control their chronic condition by 2030, predominantly in South Asia and other emerging markets.  According to WHO, 53% of deaths in India are due to chronic diseases. The issue is not limited to the increased death rates, but to the detrimental and disparaged effect on the economy of families and countries as a whole. 

The gist of the discussion

The podcast starts with an important discussion on how Digital Therapeutics differs from medical treatment. Abhishek, co-founder, and CEO at Wellthy Therapeutics explains by referencing the bullseye framework, where he compares the outermost circle to everything that comprises digital health which could be e-pharmacies, diagnostics, medicines, and others. 

The middle circle is where digital medicine comes into the picture, where the solutions are built on complete protocols and standard guidelines and are further deployed in the healthcare delivery system. 

The innermost and the most important circle represents digital therapeutics, which is the bullseye. In brief, it’s an amalgamation of software and hardware-based solutions along with telecommunication platforms that provides real-world evidence of digital therapeutics success rates. As the procedure is completely digital, hence the name ‘Digital Therapeutics’, Abhishek explains further. The testing procedures and meeting quality standards of therapeutics are the same as any other drug or medical device testing to prove its efficacy. 

Importance of upskilling chronic disease patients

As the conversation steers forwards, Abhishek explains the importance of upskilling the consumers or patients of chronic diseases and empowering them to take charge of their health with lesser costs involved in it, and further states, “Chronic disease will account for more than two-thirds of the healthcare cost because drugs, doctor consultations, and other factors are not sufficient. Digital Therapeutics is structured in a way that it acts as an add-on to the existing delivery of health care, augmenting real-world outcomes. This is not only limited to the patient, but to the family members, paramedics, or physicians monitoring them, with sufficient data to guide and monitor their patients, changing the way care is delivered.” 

Tune in to the podcast on Google Podcast, Spotify, and Apple Podcast to listen to this amazing discussion and know more about how pandemic has impacted the health care industry and how the right partnerships play a prominent role in the growth of any business. 

The discussion ends with a ket note from the speaker where Abhishek states,

“ Success is never owned, it’s rented. And the rent is due every single day.”   

About the Host

Truepush is a leading Push Notifications platform, empowering 20,000+ businesses with increased customer engagement & Retention.

Sign up now to turn your visitors into repeat customers!

Join our communities of 36,000+ marketers & developers to access original and interesting resources. We’d make sure, we never lose touch with you.


Join ourWhatsApp/Telegram community of like-minded folks!


Also, listen to: